Real-World Evidence in Medical Device Effectiveness

Abstract

Real-world evidence (RWE) -- clinical evidence derived from real-world data sources including electronic health records, device registries, claims databases, and patient-reported outcome platforms -- has emerged as a critical complement to randomised controlled trials for evaluating medical device effectiveness, particularly for implantable devices where long-term outcomes, rare complications, and population-level performance cannot be adequately captured within the controlled trial setting. This study presents the Real-World Evidence Device Effectiveness Assessment Framework (RWDEAF), evaluating five RWE generation methodologies -- registry-based cohort studies, administrative claims analysis, electronic health record (EHR) mining, patient-reported outcome (PRO) platforms, and hybrid RCT-RWE designs -- across four device effectiveness assessment tasks: long-term safety surveillance, comparative effectiveness evaluation, subgroup performance identification, and device iteration tracking. Our RWE Device Effectiveness Score (RWDES) integrates evidence validity, outcome completeness, generalisability, regulatory utility, and timeliness. Hybrid RCT-RWE designs achieved the highest RWDES (0.924) through pragmatic trial architectures that embed randomisation within routine clinical workflows while leveraging real-world data infrastructure for outcome ascertainment, and registry-based studies achieved the highest long-term safety surveillance score (0.960) through structured follow-up protocols maintaining 92% retention at 5 years across 248,000 device implantations.